UCB Pharma GmbH
Schwarz Pharma AG: Appointment of new CFO
SCHWARZ PHARMA AG / Change of Personnel Release of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- SCHWARZ PHARMA appoints new CFO Stephan Roeder appointed as new Chief Financial Officer of SCHWARZ PHARMA AG. The Supervisory Board of SCHWARZ PHARMA AG has appointed Stephan Roeder as Executive Board member with immediate effect. Within the Executive Board, Stephan Roeder will serve as Chief Financial Officer (CFO), responsible for Finance, Controlling, IT and Audit. You find more information on the internet: www.schwarzpharma.com SCHWARZ PHARMA AG is listed in the Prime Standard of the Frankfurter Wertpapierbörse (Frankfurt stock exchange) and member in the German stock index SDAX Security code no. 722 190 / ISIN no.: DE 0007221905 SCHWARZ PHARMA AG Alfred-Nobel-Str. 10 40789 Monheim Germany Corporate Communications: Antje Witte, Tel: +49 2173 48 1866 Contact: Corporate Communications: Antje Witte, Tel: +49 2173 48 1866; Bettina Ellinghorst, Tel.: +49 2173 48 2329 DGAP 13.07.2007 ---------------------------------------------------------------------- Language: English Issuer: SCHWARZ PHARMA AG Alfred-Nobel-Str. 10 40789 Monheim Deutschland Phone: +49 2173 48 1866 Fax: +49 2173 48 1856 E-mail: antje.witte@schwarzpharma.com Internet: www.schwarzpharma.com ISIN: DE0007221905 WKN: 722190 Indices: SDAX, MIDCAP, PRIMEALL, CLASSICALLSHARE, CDAX, HDAX, GEX Listed: Amtlicher Markt in Frankfurt (Prime Standard), Düsseldorf; Freiverkehr in Berlin, Hannover, Hamburg, München, Stuttgart End of News DGAP News-Service ---------------------------------------------------------------------------
Aktuelle News
Aktuelle Berichte
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden